90 related articles for article (PubMed ID: 26899668)
1. Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives.
Eissa AG; Blaxland JA; Williams RO; Metwally KA; El-Adl SM; Lashine el-SM; Baillie LW; Simons C
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1694-7. PubMed ID: 26899668
[TBL] [Abstract][Full Text] [Related]
2. Preparation, antibacterial evaluation and preliminary structure-activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives.
Ouyang L; Huang Y; Zhao Y; He G; Xie Y; Liu J; He J; Liu B; Wei Y
Bioorg Med Chem Lett; 2012 May; 22(9):3044-9. PubMed ID: 22494615
[TBL] [Abstract][Full Text] [Related]
3. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model.
Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
Zhang SJ; Yang Q; Xu L; Chang J; Sun X
Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of a Chemical Compound that Inhibits Methionyl-tRNA Synthetase from Pseudomonas aeruginosa.
Robles S; Hu Y; Resto T; Dean F; Bullard JM
Curr Drug Discov Technol; 2017; 14(3):156-168. PubMed ID: 28359232
[TBL] [Abstract][Full Text] [Related]
7. Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study.
Nayak SU; Griffiss JM; Blumer J; O'Riordan MA; Gray W; McKenzie R; Jurao RA; An AT; Le M; Bell SJ; Ochsner UA; Jarvis TC; Janjic N; Zenilman JM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584140
[No Abstract] [Full Text] [Related]
8. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors.
Farhanullah ; Kim SY; Yoon EJ; Choi EC; Kim S; Kang T; Samrin F; Puri S; Lee J
Bioorg Med Chem; 2006 Nov; 14(21):7154-9. PubMed ID: 16854585
[TBL] [Abstract][Full Text] [Related]
9. A homology model for Clostridium difficile methionyl tRNA synthetase: active site analysis and docking interactions.
Al-Moubarak E; Simons C
J Mol Model; 2011 Jul; 17(7):1679-93. PubMed ID: 21042822
[TBL] [Abstract][Full Text] [Related]
10. Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues.
Jarvest RL; Armstrong SA; Berge JM; Brown P; Elder JS; Brown MJ; Copley RC; Forrest AK; Hamprecht DW; O'Hanlon PJ; Mitchell DJ; Rittenhouse S; Witty DR
Bioorg Med Chem Lett; 2004 Aug; 14(15):3937-41. PubMed ID: 15225702
[TBL] [Abstract][Full Text] [Related]
11. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
[TBL] [Abstract][Full Text] [Related]
12. Quantitative structure activity relationship (QSAR) studies on nitazoxanide-based analogues against Clostridium difficile In vitro.
Zhang H; Liu X; Yang Y; Li J
Pak J Pharm Sci; 2016 Sep; 29(5):1681-1689. PubMed ID: 27731829
[TBL] [Abstract][Full Text] [Related]
13. 2-[2-Substituted-3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors.
Farhanullah ; Kang T; Yoon EJ; Choi EC; Kim S; Lee J
Eur J Med Chem; 2009 Jan; 44(1):239-50. PubMed ID: 18403059
[TBL] [Abstract][Full Text] [Related]
14. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of teicoplanin against Clostridium difficile.
Wongwanich S; Kusum M; Phan-Urai R
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
[TBL] [Abstract][Full Text] [Related]
17. Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).
Letourneau JJ; Stroke IL; Hilbert DW; Sturzenbecker LJ; Marinelli BA; Quintero JG; Sabalski J; Ma L; Diller DJ; Stein PD; Webb ML
Bioorg Med Chem Lett; 2018 Feb; 28(4):756-761. PubMed ID: 29331267
[TBL] [Abstract][Full Text] [Related]
18. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
[TBL] [Abstract][Full Text] [Related]
19. Discovery of LFF571: an investigational agent for Clostridium difficile infection.
LaMarche MJ; Leeds JA; Amaral A; Brewer JT; Bushell SM; Deng G; Dewhurst JM; Ding J; Dzink-Fox J; Gamber G; Jain A; Lee K; Lee L; Lister T; McKenney D; Mullin S; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Trzasko A; Whitehead L; Yifru A; Yu D; Yan W; Zhu Q
J Med Chem; 2012 Mar; 55(5):2376-87. PubMed ID: 22315981
[TBL] [Abstract][Full Text] [Related]
20. Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-positive antibacterial activity.
Jarvest RL; Berge JM; Brown P; Houge-Frydrych CS; O'Hanlon PJ; McNair DJ; Pope AJ; Rittenhouse S
Bioorg Med Chem Lett; 2003 Apr; 13(7):1265-8. PubMed ID: 12657260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
